Ventricular adrenomedullin system in the transition from LVH to heart failure in rats

Hypertension

Volumn 41, Issue 3 I, 2003, Pages 512-518

  Nishikimi, Toshio ^a   Tadokoro, Kazuyoshi ^a   Mori, Yosuke ^a   Wang, Xin ^a   Akimoto, Kazumi ^a   Yoshihara, Fumiki ^b   Minamino, Naoto ^b   Kangawa, Kenji ^b   Matsuoka, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adrenomedullin; Heart failure; Hypertension, sodium dependent; Hypertrophy, left ventricular; Rats, Dahl

Indexed keywords

ADRENOMEDULLIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; CALCITONIN RECEPTOR; ISOPROTEIN; NEUROHORMONE; RECEPTOR ACTIVITY MODIFYING PROTEIN; RENIN;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HORMONE BLOOD LEVEL; HYPERTENSION; MALE; NONHUMAN; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; RAT; SALT INTAKE; TISSUE LEVEL;

ADRENOMEDULLIN; ANIMALS; ATRIAL NATRIURETIC FACTOR; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; PEPTIDES; RATS; RATS, INBRED DAHL; RECEPTORS, CALCITONIN; TRANSCRIPTION, GENETIC;

EID: 0037336746     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000053447.64213.C4     Document Type: Article

References (35)

1. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-585.
2. Vasan RS, Levy D. The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview. Arch Intern Med. 1996;156: 1789-1796.
3. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275: 1557-1562.
4. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol. 1996;27:1214-1218.
5. Nicholls MG. Hypertension, hypertrophy, heart failure. Heart. 1996; 76(suppl 3):92-97.
6. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192: 553-560.
7. Sakata J, Shimokubo T, Kitamura K, Nishizono M, Ichiki Y, Kangawa K, Matsuo H, Eto T. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 1994;352:105-108.
8. Jougasaki M, Burnett JC Jr. Adrenomedullin: potential in physiology and pathophysiology. Life Sci. 2000;66:855-872.
9. Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol. 1995; 26:1424-1431.
10. Nagaya N, Satoh T, Nishikimi T, Uematsu M, Furuichi S, Sakamaki F, Oya H, Kyotani S, Nakanishi N, Goto Y, Masuda Y, Miyatake K, Kangawa K. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation. 2000;101:498-503.
11. Rademaker MT, Charles CJ, Lewis LK, Yandle TG, Cooper GJ, Coy DH, Richards AM, Nicholls MG. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation. 1997;96:1983-1990.
12. Lainchbury JG, Nicholls MG, Espiner EA, Yandle TG, Lewis LK, Richards AM. Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. Hypertension. 1999;34:70-75.
13. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K. Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts. Eur J Pharmacol. 1999;382:1-9.
14. Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, Tsuji T, Kangawa K, Eto T. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension. 1998;31:505-510.
15. Tsuruda T, Kato J, Kitamura K, Imamura T, Koiwaya Y, Kangawa Koiwaya Y, Kangawa K, Komuro I, Yazaki Y, Eto T. Enhanced adrenomedullin production by mechanical stretching in cultured rat cardiomyocytes. Hypertension. 2000;35:1210-1214.
16. Morimoto A, Nishikimi T, Yoshihara F, Horio T, Nagaya N, Matsuo H, Dohi K, Kangawa K. Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats. Hypertension. 1999;33:1146-1152.
17. Nishikimi T, Horio T, Sasaki T, Yoshihara F, Takishita S, Miyata A, Matsuo H, Kangawa K. Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension. 1997;30:1369-1375.
18. Nagaya N, Nishikimi T, Yoshihara F, Horio T, Morimoto A, Kangawa K. Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am J Physiol Regul Integr Comp Physiol. 2000;278:R1019-R1026.
19. Yoshihara F, Nishikimi T, Horio T, Yutani C, Takishita S, Matsuo H, Ohe T, Kangawa K. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline. Eur J Pharmacol. 1998;355:33-39.
20. Chao J, Kato K, Zhang JJ, Dobrzynski E, Wang C, Agata J, Chao L. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides. 2001;22:1731-1737.
21. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998;393: 333-339.
22. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM. International union of pharmacology, XXXII: the mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev. 2002;54:233-246.
23. Kitamura K, Kato J, Kawamoto M, Tanaka M, Chino N, Kangawa K, Eto T. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun. 1998;244:551-555,.
24. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, Sasayama S. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation. 1998;98:2065-2073.
25. Nishikimi T, Mori Y, Kobayashi N, Tadokoro K, Wang X, Akimoto K, Yoshihara F, Kangawa K, Matsuoka H. Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension. 2002; 39:1077-1082.
26. Nishikimi T, Miyata A, Horio T, Yoshihara F, Nagaya N, Takishita S, Yutani C, Matsuo H, Matsuoka H, Kangawa K. Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am J Physiol Heart Circ Physiol. 2000;279:H3031-H3039.
27. Shimokubo T, Sakata J, Kitamura K, Kangawa K, Matsuo H, Eto T. Adrenomedullin: changes in circulating and cardiac tissue concentration in Dahl salt-sensitive rats on a high-salt diet. Clin Exp Hypertens. 1996; 18:949-961.
28. Totsune K, Takahashi K, Mackenzie HS, Murakami O, Arihara Z, Sone M, Mouri T, Brenner BM, Ito S. Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptoractivity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure. Clin Sci. 2000;99:541-546.
29. Oie E, Vinge LE, Yndestad A, Sandberg C, Grogaard HK, Attramadal H. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation. 2000;101:415-422.
30. Mishima K, Kato J, Kuwasako K, Ito K, Imamura T, Kitamura K, Eto T. Effects of endothelin on adrenomedullin secretion and expression of adrenomedullin receptors in rat cardiomyocytes. Biochem Biophys Res Commun. 2001;287:264-269.
31. Hirayama N, Kitamura K, Imamura T, Kato J, Koiwaya Y, Tsuji T, Kangawa K, Eto T. Molecular forms of circulating adrenomedullin in patients with congestive heart failure. J Endocrinol. 1999;160:297-303.
32. Maltese JY, Oyarce AM, Eipper BA. Prevalence and turnover of peptidylglycine α-amidating monooxygenase mRNA in atrial cardiomyocytes. J Mol Cell Cardiol. 1996;28:155-163.
33. Lee ME, Miller WL, Edwards BS, Burnett JC Jr. Role of endogenous atrial natriuretic factor in acute congestive heart failure. J Clin Invest. 1989;84:1962-1966.
34. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A. 1997;94:14730-14735.
35. Kuwasako K, Kitamura K, Ito K, Uemura T, Yanagita Y, Kato J, Sakata T, Eto T. The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors. J Biol Chem. 2001;27:49459-49465.